RAISE raises €100M first close for private-equity fund that bankrolls French medical research
What's the deal? French investment group RAISE has closed a first €100 million for Investir pour la Recherche Médicale (IPRM), a private-equity fund that channels part of its returns into medical research. The fund targets €200 million and was announced on November 3, 2026.
Who's backing it? The €100 million came from AXA, Banque des TerritoiresDealroom has a profile for this one. Try Dealroom →, Crédit Agricole AssurancesDealroom has a profile for this one. Try Dealroom →, CARAC, and Laboratoires Pierre Fabre. IPRM will reverse half of its management fees and half of its net capital gains to four institutions: Gustave Roussy, the Institut Pasteur, the Institut Imagine, and the Fondation pour la Recherche Médicale.
How it works: IPRM is a professional private-equity fund (FPCI) regulated by the AMF, investing as a minority co-investor in buyouts and growth capital across France and Europe, with tickets of €5 million to €15 million. It leans on a network of partner management firms that surface deals — the same federated model as RAISE's first sharing fund, Investir pour l'Enfance, launched in 2023.
Why now? French research bodies face budget pressure: the CNRS announced €20 million in cost cuts and a hiring freeze in 2026. France spent an estimated €63.6 billion on R&D in 2024, or 2.2% of GDP — below the European 3% target and behind Germany (3.1%) and the US (3.4%).
What could go wrong? This is a supplementary funding model, not a €100 million grant. The amount the institutions ultimately receive depends on fees and investment performance, and the fund carries a risk of capital loss and low liquidity.
What's the endgame? RAISE manages €2 billion and already funnels up to 50% of its teams' carried interest into its endowment fund, RAISE Sherpas. IPRM extends that logic at larger scale. "With Investir pour l'Enfance, we proved the model worked. With Investir pour la Recherche Médicale, we are changing scale," said co-founder Gonzague de Blignières (translated from French).
The signal: As public research budgets tighten — the Institut Pasteur already draws more than a third of its income from private donations — investors are testing whether private-equity returns can plug the gap. RAISE is betting the model scales from its €45 million children's fund to medical research, and from there, potentially further.
Read more: finyear.com
Image credit: Generated with Gemini
